Literature DB >> 1560108

Females with a disorder phenotypically identical to X-linked agammaglobulinemia.

M E Conley1, S K Sweinberg.   

Abstract

Clinical and laboratory findings in two girls with a disorder phenotypically indistinguishable from typical X-linked agammaglobulinemia (XLA) are described. To examine the possibility that subtle defects in the X chromosome might explain the findings, detailed genetic studies were performed on one of these patients. Cytogenetic studies showed a normal 46XX karyotype. Southern blot analysis of her DNA showed that she had inherited a maternal and a paternal allele at sites flanking the locus for typical XLA at Xq22, making a microdeletion or uniparental disomy unlikely. To determine whether both of her X chromosomes could function as the active X, somatic-cell hybrids that selectively retained the active X were produced from her activated T cells. A normal random pattern of X inactivation was seen. Of 21 T-cell hybrids, 3 retained both X chromosomes, 7 had one X as the active X, and 11 had the other X as the active X. We have interpreted these studies as indicating that there is an autosomal recessive disorder that is phenotypically identical to XLA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1560108     DOI: 10.1007/bf00918144

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  24 in total

Review 1.  Definition of the gene loci in X-linked immunodeficiencies.

Authors:  M E Conley; J M Puck
Journal:  Immunol Invest       Date:  1988-07       Impact factor: 3.657

2.  Primary immunodeficiency diseases. Report of a WHO sponsored meeting.

Authors: 
Journal:  Immunodefic Rev       Date:  1989

Review 3.  Report of the DNA committee and catalogs of cloned and mapped genes and DNA polymorphisms.

Authors:  K K Kidd; A M Bowcock; J Schmidtke; R K Track; F Ricciuti; G Hutchings; A Bale; P Pearson; H F Willard; J Gelernter
Journal:  Cytogenet Cell Genet       Date:  1989

4.  Expression of the gene defect in X-linked agammaglobulinemia.

Authors:  M E Conley; P Brown; A R Pickard; R H Buckley; D S Miller; W H Raskind; J W Singer; P J Fialkow
Journal:  N Engl J Med       Date:  1986-08-28       Impact factor: 91.245

5.  Abnormal X chromosomes in man: origin, behavior and effects.

Authors:  E Therman; K Patau
Journal:  Humangenetik       Date:  1974

6.  Nonrandom X chromosome inactivation in B cells from carriers of X chromosome-linked severe combined immunodeficiency.

Authors:  M E Conley; A Lavoie; C Briggs; P Brown; C Guerra; J M Puck
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

Review 7.  X-linked agammaglobulinemia: an analysis of 96 patients.

Authors:  H M Lederman; J A Winkelstein
Journal:  Medicine (Baltimore)       Date:  1985-05       Impact factor: 1.889

8.  DXS165 detects a translocation breakpoint in a woman with choroideremia and a de novo X; 13 translocation.

Authors:  D E Merry; J G Lesko; V Siu; W F Flintoff; F Collins; R A Lewis; R L Nussbaum
Journal:  Genomics       Date:  1990-04       Impact factor: 5.736

Review 9.  Chronic enteroviral meningoencephalitis in agammaglobulinemic patients.

Authors:  R E McKinney; S L Katz; C M Wilfert
Journal:  Rev Infect Dis       Date:  1987 Mar-Apr

10.  Carrier detection in typical and atypical X-linked agammaglobulinemia.

Authors:  M E Conley; J M Puck
Journal:  J Pediatr       Date:  1988-05       Impact factor: 4.406

View more
  12 in total

Review 1.  Early B cell defects.

Authors:  H B Gaspar; M E Conley
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

Review 2.  X-linked agammaglobulinemia.

Authors:  M E Conley; J Rohrer; Y Minegishi
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

3.  The PAX5 gene: a linkage and mutation analysis in candidate human primary immunodeficiencies.

Authors:  I Vorechovský; S Koskinen; R Paganelli; C I Smith; M Busslinger; L Hammarström
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

4.  Clinical and molecular analysis of patients with defects in micro heavy chain gene.

Authors:  Eduardo Lopez Granados; Andrea S Porpiglia; Mary Beth Hogan; Nuria Matamoros; Silvia Krasovec; Claudio Pignata; C I E Smith; Lennart Hammarstrom; Janne Bjorkander; Bernd H Belohradsky; G Fontan Casariego; M C Garcia Rodriguez; Mary Ellen Conley
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

5.  Mutations in btk in patients with presumed X-linked agammaglobulinemia.

Authors:  M E Conley; D Mathias; J Treadaway; Y Minegishi; J Rohrer
Journal:  Am J Hum Genet       Date:  1998-05       Impact factor: 11.025

6.  Agammaglobulinemia associated with BCR⁻ B cells and enhanced expression of CD19.

Authors:  A Kerry Dobbs; Amma Bosompem; Elaine Coustan-Smith; Gayle Tyerman; Frank T Saulsbury; Mary Ellen Conley
Journal:  Blood       Date:  2011-06-21       Impact factor: 22.113

Review 7.  Immunogenetics: changing the face of immunodeficiency.

Authors:  A M Jones; H B Gaspar
Journal:  J Clin Pathol       Date:  2000-01       Impact factor: 3.411

8.  Application of carrier testing to genetic counseling for X-linked agammaglobulinemia.

Authors:  R C Allen; R G Nachtman; H M Rosenblatt; J W Belmont
Journal:  Am J Hum Genet       Date:  1994-01       Impact factor: 11.025

9.  X chromosome inactivation analysis to distinguish sporadic cases of X-linked agammaglobulinaemia from common variable immunodeficiency.

Authors:  I Tsuge; H Matsuoka; T Abe; Y Kamachi; S Torii
Journal:  Eur J Pediatr       Date:  1993-11       Impact factor: 3.183

10.  A human non-XLA immunodeficiency disease characterized by blockage of B cell development at an early proB cell stage.

Authors:  E Meffre; F LeDeist; G de Saint-Basile; A Deville; M Fougereau; A Fischer; C Schiff
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.